Fifth Third Bancorp’s Albireo Pharma Inc ALBO Stock Holding History

Fifth Third Bancorp’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7	Closed	–	–	2380
2019 Q3	$0	Buy	+7	New	+$181	﹤0.01%	2392

Other funds holding ALBO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fifth Third Bancorp's ALBO Position: Q4 2019 in Review

Fifth Third Bancorp sold out of Albireo Pharma Inc (ALBO) in Q4 2019, closing a stake of 7 shares.

Fifth Third Bancorp first reported a position in ALBO in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 70 funds tracked by Wall St. Rank hold ALBO as of Q4 2019.

Fifth Third Bancorp reported no remaining Albireo Pharma Inc position as of Q4 2019 after selling out during the quarter.
Fifth Third Bancorp sold 7 Albireo Pharma Inc shares in Q4 2019.
Fifth Third Bancorp first reported a position in Albireo Pharma Inc in Q3 2019 and held it in 1 quarter.
Fifth Third Bancorp's Albireo Pharma Inc position peaked at $0 in Q3 2019.
70 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.